the aid library

LIST OPTIONS

Filter

741

Sort by:

Direction:

Download (165)

View PDF (167)

Annex 3. Dosages of ARV drugs

World Health Organization (2019) C_WHO

Accessed: 19.10.2019

Download (102)

View PDF (145)

Toolkit for research and development of paediatric antiretroviral drugs and formulations

World Health Organization (WHO); Unitaid; Unicef; et al. World Health Organization (WHO); Unitaid; Unicef; et al. (2018) C_WHO

WHO and UNITAID in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group

Download (119)

View PDF (158)

Clinical Guidelines: HIV Diagnosis - Chapter 2

World Health Organization (WHO) World Health Organization (WHO) (2019) C_WHO

Accessed: 29.09.2019

Download (98)

View PDF (1281)

Practitioner Review: Posttraumatic stress disorder and its treatment in children and adolescents

Patrick Smith, T. Dalgleish and R. Meiser‐Stedman (2019) CC

Journal of Child Psychology and Psychiatry60:5 (2019), pp 500–515

Download (163)

View PDF (175)

Caregiving and Experiences of Health, Illness and Coping in the Context of Paediatric and Adolescent HIV and Poverty

A. G. Lentoor Web of Science; INTECH (2018) C2

We are IntechOpen, the world’s leading publisher of Open Access books Built by scientists, for scientists Selection of our books indexed in the Book Citation Index in Web of ScienceTM Core Collection (BKCI) http://dx.doi.org/10.5772/intechopen.68759

Download (205)

View PDF (244)

New heroin-assisted treatment - Recent evidence and current practices of supervised injectable heroin treatment in Europe and beyond

J. Strang; T. Groshkova; N. Metrebian European Monitoring Centre for Drugs and Drug Addiction; Publications Office (2019) C2

EMCDDA Insights - 11 Accessed: 14.03.2019

Download (227)

View PDF (344)

Improving health and learning through better water, sanitation and hygiene in schools

World Health Organization WHO, Regional Office for Europe; UNICEF; UNESCO (2019) C_WHO

An information package for school staff

Download (250)

View PDF (176)

Surveillance of water, sanitation and hygiene in schools. A pratical tool

World Health Organization WHO, Regional Office for Europe (2019) C_WHO

This publication provides a practical tool to support countries in strengthening surveillance of WASH in schools. The findings will inform the development of supportive regulations and improvement planning to safeguard children’s health, well-being, dignity and cognitive performance. The tool also... more

Download (137)

View PDF (198)

Access to hepatitis C testing and treatment for people who inject drugs and people in prisons – a global perspective. Policy brief

World Health Organization WHO (2019) C_WHO

Download (117)

View PDF (145)

Clinical Guidelines: Antiretroviral drugs for HIV prevention - Chapter 3

World Health Organization (2019) C_WHO

Accessed: 27.11.2019

Download (159)

View PDF (235)

Epidemiology of alcohol use in the WHO South-East Asia Region

World Health Organization (WHO), Regional Office for South-East-Asia (2018) C_WHO

This publication outlines public health aspects of alcohol use and harm in WHO South East Asia Region Countries. It summarizes Global Regional and country specific data and also discusses aspects of alcohol control that are important in the context of the Region. The possible future trend of alcohol... more

Download (379)

View PDF (328)

WHO report on cancer: setting priorities, investing wisely and providing care for all

World Health Organization WHO (2020) C1

Ramped-up cancer services could save 7 million lives over the next decade—and addressing huge service gaps between rich and poor countries is key to success, according to this report. In 2019, over 90% of high-income countries reported that comprehensive cancer treatment services were available... more

Download (83)

View PDF (736)

It’s better together! European perspective on benefits and challenges associated with cross-border health communication campaigns

Rodrigues R., S. Ilinca, K. Schulmann PLOS ONE (2018) C1

PLOSONE| https://doi.org/10.1371/journal.pone.0204882October17,2018

Download (85)

View PDF (639)

Sustainability and the common good: Catholic Social Teaching and ‘Integral Ecology’ as contributions to a framework of social values for sustainability transitions

Christie, I.; Gunton R. M., Hejnowicz A.P. IR3S (2019) C1

Sustainability Science (2019) 14:1343–1354

Download (163)

View PDF (171)

Survive and Thrive: Transforming care for every small and sick newborn

World Health Organization (2019) C_WHO

Just about everyone has experienced the joy that a healthy newborn child brings to parents, families and communities. But the arrival of a newborn who is small or sick often results in immediate worry and sadness. When the infant is at high risk of death or disability, these concerns can be a tremen... more

Download (184)

View PDF (162)

СТАНДАРТЫ ПОВЫШЕНИЯ КАЧЕСТВА МЕДИЦИНСКОЙ ПОМОЩИ, ОКАЗЫВАЕМОЙ МАТЕРЯМ И НОВОРОЖДЕННЫМ В ЛЕЧЕБНЫХ УЧРЕЖДЕНИЯХ

Всемирная организация здравоохранения (2018) C_WHO

Download (101)

View PDF (153)

National Antenatal Sentinel HIV Survey Key Findings, South Africa 2017

south (2019) CC

Download (110)

View PDF (173)

At Heart, Global Health Draws on Compassion, Solidarity and Justice

Addiss, D. (2018) CC

Download (104)

View PDF (115)

Expanding the Single-Visit Approach for Cervical Cancer Prevention: Successes and Lessons From Burkina Faso

Ouedraogo Y., Furlane G., Fruhauf T. et al. Global Health: Science and Practice (2018) CC

Background: Cervical cancer accounts for 23% of cancer incidence and 22% of cancer mortality among women in Burkina Faso. These proportions are more than 2 and 5 times higher than those of developed countries, respectively. Before 2010, cervical cancer prevention (CECAP) services in Burkina Faso wer...e limited to temporary screening campaigns. Program Description: Between September 2010 and August 2014, program implementers collaborated with the Ministry of Health and professional associations to implement a CECAP program focused on coupling visual inspection with acetic acid (VIA) for screening with same-day cryotherapy treatment for eligible women in 14 facilities. Women with larger lesions or lesions suspect for cancer were referred for loop electrosurgical excision procedure (LEEP). The program trained providers, raised awareness through demand generation activities, and strengthened monitoring capacity. Methods: Data on program activities, service provision, and programmatic lessons were analyzed. Three data collection tools, an individual client form, a client registry, and a monthly summary sheet, were used to track 3 key CECAP service indicators: number of women screened using VIA, proportion of women who screened VIA positive, and proportion of women screening VIA positive who received same-day cryotherapy. Results: Over 4 years, the program screened 13,999 women for cervical cancer using VIA; 8.9% screened positive; and 65.9% received cryotherapy in a single visit. The proportion receiving cryotherapy on the same day started at a high of 82% to 93% when services were provided free of charge, but dropped to 51% when a user fee of $10 was applied to cover the cost of supplies. After reducing the fee to $4 in November 2012, the proportion increased again to 78%. Implementation challenges included difficulties tracking referred patients, stock-outs of key supplies, difficulties with machine maintenance, and prohibitive user fees. Providers were trained to independently monitor services, identify gaps, and take corrective actions. Conclusions: Following dissemination of the results that demonstrated the acceptability and feasibility of the CECAP program, the Burkina Faso Ministry of Health included CECAP services in its minimum service delivery package in 2016. Essential components for such programs include provider training on VIA, cryotherapy, and LEEP; provider and patient demand generation; local equipment maintenance; consistent supply stocks; referral system for LEEP; non-prohibitive fees; and a monitoring data collection system. more

Download (136)

View PDF (173)

Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map

Van Katwyk, S. R.; Grimshaw, J. M.; et al (2019) C2

BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidenc...e map can support governments in making evidence-informed decisions about implementing programs to reduce AMR, by identifying, describing, and assessing the full range of evaluated government policy options to reduce antimicrobial use in humans. METHODS AND FINDINGS: Seven databases were searched from inception to January 28, 2019, (MEDLINE, CINAHL, EMBASE, PAIS Index, Cochrane Central Register of Controlled Trials, Web of Science, and PubMed). We identified studies that (1) clearly described a government policy intervention aimed at reducing human antimicrobial use, and (2) applied a quantitative design to measure the impact. We found 69 unique evaluations of government policy interventions carried out across 4 of the 6 WHO regions. These evaluations included randomized controlled trials (n = 4), non-randomized controlled trials (n = 3), controlled before-and-after designs (n = 7), interrupted time series designs (n = 25), uncontrolled before-and-after designs (n = 18), descriptive designs (n = 10), and cohort designs (n = 2). From these we identified 17 unique policy options for governments to reduce the human use of antimicrobials. Many studies evaluated public awareness campaigns (n = 17) and antimicrobial guidelines (n = 13); however, others offered different policy options such as professional regulation, restricted reimbursement, pay for performance, and prescription requirements. Identifying these policies can inform the development of future policies and evaluations in different contexts and health systems. Limitations of our study include the possible omission of unpublished initiatives, and that policies not evaluated with respect to antimicrobial use have not been captured in this review. CONCLUSIONS: To our knowledge this is the first study to provide policy makers with synthesized evidence on specific government policy interventions addressing AMR. In the future, governments should ensure that AMR policy interventions are evaluated using rigorous study designs and that study results are published. more